3-(5-(1,5-Dimethyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid

Catalog No. :
ACDSLL274
CAS No. :
1174878-30-8
Molecular Formula :
C14H13F3N6O2
Molecular Weight :
354.29

IUPAC Name:3-(5-(1,5-dimethyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid

3-(5-(1,5-Dimethyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$281.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(5-(1,5-Dimethyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid
IUPAC Name3-(5-(1,5-dimethyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid
MDL No.MFCD12405243
Molecular FormulaC14H13F3N6O2
Molecular Weight354.29
SMILESO=C(O)CCC1=NN2C(C(F)(F)F)=CC(C3=C(C)N(C)N=C3)=NC2=N1
InChI KeyFYYPIAHNIVNUTH-UHFFFAOYSA-N
Synonym3-[5-(1,5-dimethyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]propanoic acid;[1,2,4]Triazolo[1,5-a]pyrimidine-2-propanoic acid, 5-(1,5-dimethyl-1H-pyrazol-4-yl)-7-(trifluoromethyl)-
CAS No.1174878-30-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDSLL274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSLL274 route product structure diagram
    ACDSLL2741174878-30-8
Inquiry

2. ACDSLL274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDSLL274 route product structure diagram
    ACDSLL2741174878-30-8
Inquiry

Comments (0)